View in EDS HTML Full Text PDF Full Text

Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial

Saved in:
Bibliographic Details
Title: Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial
Authors: Tanaka, Atsushi1 (AUTHOR) tanakaa2@cc.saga-u.ac.jp, Shimabukuro, Michio2 (AUTHOR), Machii, Noritaka2 (AUTHOR), Teragawa, Hiroki3 (AUTHOR), Okada, Yosuke4 (AUTHOR), Shima, Kosuke R.5 (AUTHOR), Takamura, Toshinari5 (AUTHOR), Taguchi, Isao6 (AUTHOR), Hisauchi, Itaru6 (AUTHOR), Toyoda, Shigeru7 (AUTHOR), Matsuzawa, Yasushi8 (AUTHOR), Tomiyama, Hirofumi9 (AUTHOR), Yamaoka‐Tojo, Minako10 (AUTHOR), Ueda, Shinichiro11 (AUTHOR), Higashi, Yukihito12 (AUTHOR), Node, Koichi1 (AUTHOR)
Source: Journal of Diabetes Investigation. Nov2020, Vol. 11 Issue 6, p1551-1563. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20401116
DOI:10.1111/jdi.13289